Amicus Therapeutics, Inc. (FOLD)

14.36 +0.04 (+0.31%) USD  |  NASDAQ  |  Jan 14, 16:00
14.38 +0.02 (+0.10%) After-Hours: 19:11
More

Amicus Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for FOLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
CorMedix, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Ekso Bionics Holdings, Inc. Upgrade
Gilead Sciences, Inc. Upgrade